Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vela Diagnostics offers a broad portfolio of over 30 research or IVD tests across nine disease areas. Their integrated Sentosa platform enables laboratories to perform both real-time PCR and next-generation sequencing for infectious diseases and oncology applications. The company has achieved ISO 13485 certification for its R&D and manufacturing facilities in Singapore and operates a CLIA-certified laboratory in the United States. They have launched CE-IVD marked products in Europe/Asia-Pacific regions but regulatory status varies by region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vela Diagnostics.